US Patent 9816081 Engineered nucleic-acid targeting nucleic acids
Patent 9816081 was granted and assigned to Caribou Biosciences on November, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9816081 Engineered nucleic-acid targeting nucleic acids
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.